Drug Database
PA

pancrelipase (Ultrase MT20 / Ultrase MT / Ultresa)

✓ Approved

Adare Pharma Solutions · PNLIP

什么是 pancrelipase?

pancrelipase 是一种治疗药物,由Adare Pharma Solutions研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Ultrase MT20, Ultrase MT, Ultresa
公司Adare Pharma Solutions
分子靶点PNLIP
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

pancrelipase 作用于 1 个分子靶点:

PNLIPpancreatic lipase (PL, PNLIPD)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

pancrelipase 针对 3 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
InvestigationsFaecal fat increased✓ Approved
Gastrointestinal disordersSteatorrhoea✓ Approved
Gastrointestinal disordersPancreatic failure✓ Approved

相关研究文献

PubMedCellular and molecular life sciences : CMLS2026-11-19

Targeting the Thy-1 mechanotransduction regulator rescues regenerative wound healing and induces hair follicle neogenesis under high tension.

Zhao Hao-Ran HR, Wang Fu-Chen FC, Yue Jin J, Xue Ling-Fa LF et al.

Mechanical tension is a critical driver of hypertrophic scar (HS) formation, primarily by inducing the differentiation of fibroblasts into pathological myofibroblasts. However, the upstream mechanotransduction regulators that initiate this fibrotic cell fate switch remain poorly understood. This study investigates the role of the glycoprotein Thy-1 (CD90) as a mechanotransduction regulator and its regulation of the p38MAPK signaling pathway under high-tension conditions. We established a murine high-tension scar model to simulate pathological scarring in vivo. Recombinant adeno-associated virus (rAAV) vectors were administered to locally knock down or overexpress Thy-1. Results demonstrated that Thy-1 was significantly upregulated and activated by high tension. Local knockdown of Thy-1 significantly reduced scar area and promoted orderly collagen arrangement. Crucially, Thy-1 silencing shifted the healing process toward functional regeneration, evidenced by the neogenesis of hair follicles and sebaceous glands. Mechanistically, silencing Thy-1 suppressed the downstream pro-fibrotic program, including p38MAPK phosphorylation, transforming growth factor-beta (TGF-β) expression, alpha-smooth muscle actin (α-SMA) levels, and excessive deposition of Collagen I and III. In vitro studies indicated that Thy-1 knockdown enhanced fibroblast proliferation and migration, suggesting its pathological role lies in driving terminal fibrotic differentiation. The Thy-1/p38MAPK axis acts as a crucial mechanotransduction pathway governing fibroblast-to-myofibroblast differentiation. Targeting this axis represents a promising therapeutic strategy to switch cell fate during healing, preventing pathological scarring and promoting functional skin regeneration.

PMID 43052516
阅读全文 →
PubMedThe Journal of organic chemistry2026-11-19

Bicytochalasins A-E: TRAIL-Sensitizing Cytochalasan Dimers Incorporating an Open-Chain Monomer from Phoma multirostrata XJ-2-1.

Peng Xiaogang X, Li Wan-Peng WP, Chen Zhe Z, Lai Suitian S et al.

Five potent TRAIL-sensitizing cytochalasan dimers with unprecedented chemical architectures, named bicytochalasins A-E (1-5), were isolated from the culture of the endophytic fungus Phoma multirostrata XJ-2-1. Compounds 1-5 consist of a typical tricyclic cytochalasan unit and an open-chain cytochalasan moiety, representing the first reported case of cytochalasan dimerization involving an open-chain monomer. These molecules possess two distinct carbon skeletons, each featuring a tetracyclic 5/6/14/6 ring system formed via intermolecular Diels-Alder reactions. Their structures with absolute configurations were elucidated by comprehensive spectroscopic data analysis, electronic circular dichroism (ECD) calculations, and 13C{1H} NMR chemical shift calculation. Compounds 1-5 effectively reverse TRAIL resistance in A549 cells, outperforming the positive control luteolin. Cotreatment with TRAIL (150 ng/mL) and either compound 1 or 5 (10 μM) reduced cell viability by 47.66% and 46.07%, respectively, compared to only 30.22% reduction with luteolin (25 μM). These findings identify bicytochalasins A-E (1-5) as a novel class of TRAIL-sensitizing agents.

PMID 43053606
阅读全文 →
PubMedJournal of receptor and signal transduction research2026-11-19

Computational identification and comparative characterization of ligand scaffolds for VEGFR-1 and VEGFR-2 kinase domains in neovascular age-related macular degeneration.

Li Jiawei J, Lei Siyu S, Liu Yi Y, Chen Kai K et al.

VEGFR-1 and VEGFR-2 have distinct but complementary roles in vascular endothelial growth factor signaling, providing a rationale for comparing ligand recognition by their kinase domains in neovascular age-related macular degeneration. We integrated dual-receptor docking, fragment tree Transformer-based variational autoencoder generation, and three-dimensional Monte Carlo tree search to identify candidate ligand scaffolds. Screening 37,445 natural product-like structures retained 989 compounds, and subsequent molecular generation and physicochemical filtering produced 1,315 structures for receptor-constrained optimization. Twenty candidates were prioritized, of which VDS-1, VDS-2, and VDS-3 were examined using three independent 100 ns molecular dynamics simulations per complex and MM/PBSA analysis. VDS-1 showed the most negative MM/PBSA estimates for VEGFR-2 (-49.79 ± 0.21 kcal/mol) and VEGFR-1 (-45.95 ± 1.84 kcal/mol), whereas VDS-2 exhibited substantial between-trajectory variability. VDS-3 showed limited between-trajectory variation in its MM/PBSA estimates for both receptors, although protein-aligned ligand RMSD revealed between-replicate heterogeneity, particularly in VEGFR-1. Van der Waals interactions predominated among favorable modeled contributions, with PHE1047 in VEGFR-2 and ILE881 in VEGFR-1 emerging as recurrent interaction regions. Although VDS-1 showed favorable modeled interactions, it had substantial physicochemical and predicted safety liabilities. VDS-3 therefore represented a comparatively balanced starting scaffold for further optimization, although experimental validation and toxicity assessment remain necessary.

PMID 43053624
阅读全文 →
PubMedBMC endocrine disorders2026-11-19

One-hour plasma glucose identifies metabolic subgroups in individuals with HbA1c-defined prediabetes and normal fasting and 2-hour glucose.

Ouyang Ling L, Nie Qianwen Q, Huang Youyuan Y, Qiu Xue X et al.

This study evaluated whether 1-hour postload glucose (1-h PG) identifies distinct metabolic subgroups with differing OGTT-derived β-cell function indices among Chinese adults with HbA1c-defined prediabetes and normal fasting and 2-hour glucose. This cross-sectional study included 8,537 Chinese adults undergoing 75-g OGTT and HbA1c testing. Participants were stratified into four glycemic phenotypes based on HbA1c (≥5.7%) and OGTT criteria. Within the HbA1c+/OGTT- subgroup (n=922), individuals were further classified by 1-h PG (cutoff 8.6 mmol/L). β-cell function was assessed using the disposition index (DI). Linear mixed-effects models analyzed glucose and insulin dynamics. Among 3,800 individuals with prediabetes, 24.3% exhibited isolated HbA1c elevation (HbA1c+/OGTT-). Within this discordant subgroup, 51.8% had elevated 1-h PG (≥8.6 mmol/L). The 1-h PG+ subgroup demonstrated lower β-cell function (DI = 40.47), delayed glucose peaks (60 min), impaired early-phase insulin secretion, and greater overall glycaemic exposure, whereas the 1-h PG- subgroup exhibited preserved or enhanced β-cell function (DI = 85.19 vs. 75.56 in NGT, P < 0.001). Multivariable linear regression analysis demonstrated that 1-h PG remained significantly associated with β-cell function after adjustment for age, sex, and HbA1c. Among individuals with HbA1c-defined prediabetes and normal Fasting and 2-Hour Glucose, 1-hour plasma glucose identifies subgroups with differing metabolic profiles and β-cell function. These findings highlight substantial metabolic heterogeneity within this population. However, given the cross-sectional design of the study, longitudinal investigations are required to determine whether these metabolic differences translate into differences in future diabetes risk and clinical outcomes. Not applicable.

PMID 43052968
阅读全文 →
PubMedLuminescence : the journal of biological and chemical luminescence2026-11-19

Molecularly Engineered Triphenylamine-Based Schiff Base Co-Sensitizers for DSSCs With Liquid and PAN/PEG Polymer Gel Electrolytes and for 12% Efficient Tandem Devices With Liquid Electrolyte.

Abumelha Hana M HM, Osra Khalid A KA, Alshahrani Maryam M, Alshammari Nadiyah M NM et al.

Two novel triphenylamine-based donor-π-acceptor Schiff base sensitizers, TBY-1 and TBC-1, were systematically designed, synthesized, and assessed as co-sensitizers with N719 for the enhancement photovoltaic performance. The two dyes were constructed to probe the effect of acceptor engineering on light harvesting, charge-transfer characteristics, and device efficiency. Spectroscopic analysis showed that TBC-1 exhibited broader and more red-shifted visible absorption than TBY-1, indicating stronger intramolecular charge transfer and improved solar-spectrum utilization. Density functional theory and complementary electronic analyses further confirmed that TBC-1 possesses enhanced electron delocalization, stronger donor-acceptor separation, and more favorable interfacial electronic characteristics. When co-sensitized with N719, both dyes significantly improved the photovoltaic performance relative to N719 alone in both liquid and PAN/PEG polymer gel electrolytes. The best liquid-electrolyte device, based on TBC-1 + N719, achieved a power conversion efficiency of 11.98% with VOC = 0.740 V, JSC = 23.50 mA cm-2, and FF = 68.89%, while the corresponding quasi-solid-state device retained a high efficiency of 10.45%. Upon using parallel tandem DSSC with the N719 (top)/TBC-1 (bottom) delivering the highest efficiency of 12.34% under AM 1.5G illumination. Electrochemical impedance and Bode analyses revealed that the improved performance originated from enhanced light harvesting, suppressed interfacial recombination, and prolonged electron lifetime, while long-term stability measurements demonstrated excellent operational durability over 300 h of continuous illumination. These findings highlight acceptor engineering and tandem sensitization as effective strategies for developing efficient and stable next-generation DSSCs.

PMID 43053595
阅读全文 →
PubMedBMC infectious diseases2026-11-19

Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of incident infection and severe infection-related outcomes in type 2 diabetes.

Wu Jheng-Yan JY, Lee Keng-Wei KW, Huang Sheng-Chi SC, Chang Hsuan-Yuan HY et al.

Patients with type 2 diabetes mellitus (T2DM) are at increased risk of infection-related morbidity and mortality. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may exert immunomodulatory effects beyond glycemic control. Tirzepatide, a dual glucose-dependent insulinotropic peptide and GLP-1 receptor agonist, has demonstrated superior metabolic efficacy, but its association with infection-related outcomes remains unclear. We conducted a retrospective cohort study using the TriNetX research network including adults with T2DM between January 2022 and November 2025. New users of tirzepatide were compared with new users of GLP-1RAs. Propensity score matching (1:1) balanced demographic characteristics, comorbidities, medications, and laboratory variables. The primary endpoint was a composite of infection-related events within 1 year. Secondary outcomes included pneumonia, skin infection, and all-cause mortality. Cox proportional hazards models were used to estimate hazard ratios (HRs). After matching, 143,288 patients were included in each group. Tirzepatide initiation was associated with a modestly lower risk of composite infection-related events compared with GLP-1RAs (HR 0.97, 95% CI 0.95-0.99). Lower risks were observed for pneumonia (HR 0.95, 95% CI 0.92-0.98), skin infection (HR 0.96, 95% CI 0.93-0.99), and all-cause mortality (HR 0.89, 95% CI 0.82-0.98). Results were consistent across most prespecified subgroups and sensitivity analyses, including landmark analyses and a negative control outcome. No significant differences were observed for acute pyelonephritis or gastrointestinal infection. In this large real-world cohort of patients with T2DM, tirzepatide use was associated with a modestly lower risk of infection-related outcomes compared with GLP-1RAs. These findings suggest that dual GIP/GLP-1 receptor agonism may be associated with differences in infection-related outcomes, although prospective studies are needed to confirm causality.

PMID 43052794
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多pancrelipase